Net Margin - MaxCyte Inc (NASDAQ:MXCT) - Alpha Spread
M

MaxCyte Inc
NASDAQ:MXCT

Watchlist Manager
MaxCyte Inc
NASDAQ:MXCT
Watchlist
Price: 4.06 USD -0.98% Market Closed
Market Cap: 425.6m USD
Have any thoughts about
MaxCyte Inc?
Write Note

Net Margin
MaxCyte Inc

-78%
Current
-70%
Average
0%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-78%
=
Net Income
-35.4m
/
Revenue
45.4m

Net Margin Across Competitors

Country US
Market Cap 425.6m USD
Net Margin
-78%
Country US
Market Cap 1.4T USD
Net Margin
6%
Country US
Market Cap 232.4B USD
Net Margin
15%
Country US
Market Cap 196.9B USD
Net Margin
19%
Country KR
Market Cap 70.5T KRW
Net Margin
24%
Country CH
Market Cap 38.5B CHF
Net Margin
9%
Country US
Market Cap 44.7B USD
Net Margin
9%
Country US
Market Cap 39.7B USD
Net Margin
22%
Country US
Market Cap 29.8B USD
Net Margin
21%
Country IE
Market Cap 25.3B USD
Net Margin
9%
Country US
Market Cap 22.6B USD
Net Margin
18%

Profitability Report

View the profitability report to see the full profitability analysis for MaxCyte Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-78%
=
Net Income
-35.4m
/
Revenue
45.4m
What is the Net Margin of MaxCyte Inc?

Based on MaxCyte Inc's most recent financial statements, the company has Net Margin of -78%.